Breaking

Tweet TWEET

Syneron Medical to Present at Three Investor Conferences in November

     Syneron Medical to Present at Three Investor Conferences in November

PR Newswire

YOKNEAM, Israel, Nov. 11, 2013

YOKNEAM, Israel, Nov. 11, 2013 /PRNewswire/ --Syneron Medical Ltd. (NASDAQ:
ELOS), the leading global aesthetic device company, announced today that Dr.
Shimon Eckhouse, Chief Executive Officer, and Hugo Goldman, Chief Financial
Officer, are scheduled to participate in three upcoming investor conferences.

(Logo: http://photos.prnewswire.com/prnh/20120528/535447)

The first conference is the Canaccord Genuity Medical Technologies &
Diagnostics Forum in New York City. Dr. Eckhouse will participate on behalf of
the Company.

  Conference: Canaccord Genuity Medical Technologies & Diagnostics Forum
  Date:  Thursday, November 14, 2013
  Time:  1:00 pm ET

The second conference is the Barclays Select Growth Conference in New York
City. Dr. Eckhouse will participate on behalf of the Company.

  Conference: Barclays Select Growth Conference
  Date:  Monday, November 18, 2013
  Time:  11:30 am ET

The third conference is the Jefferies 2013 Global Healthcare Conference in
London. Mr. Goldman will participate on behalf of the Company.

  Conference: Jefferies 2013 Global Healthcare Conference
  Date:  Wednesday, November 20, 2013
  Time:  8:00 am GMT (3:00 am ET)

The presentations will be webcast live over the Internet and can be accessed
through the Investor Relations section on Syneron's website at
www.investors.syneron.com. Please go to the website a few minutes early, as it
may be necessary to download audio software to hear the presentations.

About Syneron Medical Ltd.
Syneron Medical Ltd. (NASDAQ: ELOS) is the leading global aesthetic device
company with a comprehensive product portfolio and a global distribution
footprint. The Company's technology enables physicians to provide advanced
solutions for a broad range of medical-aesthetic applications including body
contouring, hair removal, wrinkle reduction, rejuvenation of the skin's
appearance through the treatment of superficial benign vascular and pigmented
lesions, and the treatment of acne, leg veins and cellulite. The Company sells
its products under two distinct brands, Syneron and Candela. Founded in 2000,
the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd.
are located in Israel. Syneron also has R&D and manufacturing operations in
the US. The Company markets and services and supports its products in 90
countries. It has offices in North America, France, Germany, Italy, Portugal,
Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.

SOURCE Syneron Medical Ltd.

Website: http://www.syneron-candela.com
Contact: Hugo Goldman, Chief Financial Officer, + 972 73 244 2283, Email:
hugo.goldman@syneron.com; Zack Kubow, The Ruth Group, 646-536-7020, Email:
zkubow@theruthgroup.com
 
Press spacebar to pause and continue. Press esc to stop.